{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:00:46Z","timestamp":1789506046670,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In ovarian cancer frequently reported side effects are muscle wasting and malnutrition, leading to frailty, decreased health-related quality of life (HRQoL), and cancer-related fatigue (CRF). Both often begin during first-line chemotherapy and develop progressively into a refractory state, if left untreated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Primary objective is to evaluate effectiveness of a newly developed app-based exercise and nutrition program under non-standardized conditions of clinical routine. We hypothize that patients who receive an individually tailored exercise and nutrition program for six months will have improved physical performance compared to patients who receive usual care. This is a multicenter randomized controlled open-label trial comparing an intervention group receiving a six-month exercise and nutrition intervention and a control group receiving usual care. Primary endpoint is the change in 6-Minute Walk Test (6MWT) from baseline to T2 (26 weeks after baseline) as a measure of physical functioning. Secondary endpoints include patients\u2019 utilization and adherence to the nutrition program (MEDAS), their malnutrition risk (NRS2002), as well as patients\u2019 HRQoL (see Table\u00a01). Using the two-sample t-test with a two-sided type I error of 5% and 80% power, a medium effect size of Cohen\u2019s d\u2009=\u20090.50 can be demonstrated with a minimum of 128 participants (64 per group). With a conservatively estimated dropout rate of 30%, 182 patients will be recruited. Patients who are included must be over 18 years of age, be diagnosed with ovarian cancer, cancer of fallopian tubes, or peritoneal cancer, FIGO stages II-IV, receive surgery and chemotherapy (adjuvant or neoadjuvant). Exclusion criteria are an ECOG status greater than 2, inadequate proficiency in German, or physical or mental impairments hindering the implementation of the program or execution of study procedures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>In case of success, the project contributes in the long term to (i) improving medical care (diagnosis, psychoeducation, patient orientation, and empowerment), (ii) reducing the burden of disease and promoting physical autonomy for patients, and (iii) being incorporated into relevant guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered at ClinicalTrials.gov (NCT06250686).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-13102-y","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:56:37Z","timestamp":1731311797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Tabea","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Belau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-C.","family":"Zyriax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chang-Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Daubmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Glismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Woopen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kiechle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"13102_CR1","unstructured":"Cancer in. Germany 2019\/2020. 14th edition ed. Berlin: Robert Koch Institute, editor and the Association of \u00ad Population-based Cancer Registries in Germany, editor; 2024."},{"issue":"4","key":"13102_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/IGC.0000000000000349","volume":"25","author":"D Mizrahi","year":"2015","unstructured":"Mizrahi D, Naumann F, Broderick C, Samara J, Ryan M, Friedlander M. <ArticleTitle Language=\u201cEn\u201d>Quantifying physical activity and the associated barriers for women with ovarian cancer. Int J Gynecol Cancer. 2015;25(4):577\u201383.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"13102_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/annonc\/mdu012","volume":"25","author":"D Schmid","year":"2014","unstructured":"Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Annals oncology: official J Eur Soc Med Oncol. 2014;25(7):1293\u2013311.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"12","key":"13102_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/bjc.2017.120","volume":"116","author":"MC Playdon","year":"2017","unstructured":"Playdon MC, Nagle CM, Ibiebele TI, Ferrucci LM, Protani MM, Carter J, et al. Pre-diagnosis diet and survival after a diagnosis of ovarian cancer. Br J Cancer. 2017;116(12):1627\u201337.","journal-title":"Br J Cancer"},{"issue":"13","key":"13102_CR5","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1200\/JCO.2007.14.6217","volume":"26","author":"CM Blanchard","year":"2008","unstructured":"Blanchard CM, Courneya KS, Stein K. Cancer survivors\u2019 adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society\u2019s SCS-II. J Clin Oncol. 2008;26(13):2198\u2013204.","journal-title":"J Clin Oncol"},{"issue":"6","key":"13102_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/1055-9965.EPI-10-1173","volume":"20","author":"ML McCullough","year":"2011","unstructured":"McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, Doyle C, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1089\u201397.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"13102_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ygyno.2007.03.033","volume":"106","author":"C Stevinson","year":"2007","unstructured":"Stevinson C, Faught W, Steed H, Tonkin K, Ladha AB, Vallance JK, et al. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol. 2007;106(1):244\u201350.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"13102_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/ijgc-2023-004531","volume":"33","author":"MG Inci","year":"2023","unstructured":"Inci MG, Sehouli J, Schnura E, Lee M, Roll S, Reinhold T, et al. The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design. Int J Gynecol Cancer. 2023;33(8):1304\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"13102_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/ijgc-2019-000585","volume":"30","author":"T Maurer","year":"2020","unstructured":"Maurer T, von Grundherr J, Patra S, Jaeger A, Becher H, Schmalfeldt B, et al. An exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA study): a randomized controlled pilot trial. Int J Gynecol Cancer. 2020;30(4):541\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"13102_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/IGC.0000000000000460","volume":"25","author":"D Mizrahi","year":"2015","unstructured":"Mizrahi D, Broderick C, Friedlander M, Ryan M, Harrison M, Pumpa K, et al. An Exercise Intervention During Chemotherapy for Women With Recurrent Ovarian Cancer: A Feasibility Study. Int J Gynecol Cancer. 2015;25(6):985\u201392.","journal-title":"Int J Gynecol Cancer"},{"key":"13102_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/1471-2407-11-389","volume":"11","author":"MJ Newton","year":"2011","unstructured":"Newton MJ, Hayes SC, Janda M, Webb PM, Obermair A, Eakin EG, et al. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 2011;11:389.","journal-title":"BMC Cancer"},{"issue":"1","key":"13102_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1757-2215-6-21","volume":"6","author":"SH Moonsammy","year":"2013","unstructured":"Moonsammy SH, Guglietti CL, Santa Mina D, Ferguson S, Kuk JL, Urowitz S, et al. A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients. J Ovarian Res. 2013;6(1):21.","journal-title":"J Ovarian Res"},{"issue":"3","key":"13102_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ygyno.2011.05.029","volume":"122","author":"CM Donnelly","year":"2011","unstructured":"Donnelly CM, Blaney JM, Lowe-Strong A, Rankin JP, Campbell A, McCrum-Gardner E, et al. A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol Oncol. 2011;122(3):618\u201324.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"13102_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ygyno.2011.04.043","volume":"122","author":"VE von Gruenigen","year":"2011","unstructured":"von Gruenigen VE, Frasure HE, Kavanagh MB, Lerner E, Waggoner SE, Courneya KS. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011;122(2):328\u201333.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"13102_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ygyno.2011.11.031","volume":"124","author":"RJ Paxton","year":"2012","unstructured":"Paxton RJ, Garcia-Prieto C, Berglund M, Hernandez M, Hajek RA, Handy B, et al. A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012;124(3):410\u20136.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"13102_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1054773814559046","volume":"25","author":"KH Hwang","year":"2016","unstructured":"Hwang KH, Cho OH, Yoo YS. The Effect of Comprehensive Care Program for Ovarian Cancer Survivors. Clin Nurs Res. 2016;25(2):192\u2013208.","journal-title":"Clin Nurs Res"},{"key":"13102_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cct.2016.07.005","volume":"49","author":"CA Thomson","year":"2016","unstructured":"Thomson CA, Crane TE, Miller A, Garcia DO, Basen-Engquist K, Alberts DS. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology\/Gynecologic Oncology Group (GOG-225) Study. Contemp Clin Trials. 2016;49:181\u20139.","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"13102_CR18","doi-asserted-by":"publisher","first-page":"e036854","DOI":"10.1136\/bmjopen-2020-036854","volume":"10","author":"S Stelten","year":"2020","unstructured":"Stelten S, Hoedjes M, Kenter GG, Kampman E, Huijsmans RJ, van Lonkhuijzen LR, et al. Rationale and study protocol of the Physical Activity and Dietary intervention in women with OVArian cancer (PADOVA) study: a randomised controlled trial to evaluate effectiveness of a tailored exercise and dietary intervention on body composition, physical function and fatigue in women with ovarian cancer undergoing chemotherapy. BMJ Open. 2020;10(11):e036854.","journal-title":"BMJ Open"},{"issue":"4","key":"13102_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1188\/02.CJON.235-238","volume":"6","author":"DD Dell","year":"2002","unstructured":"Dell DD. Cachexia in patients with advanced cancer. Clin J Oncol Nurs. 2002;6(4):235\u20138.","journal-title":"Clin J Oncol Nurs"},{"issue":"7","key":"13102_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/annonc\/mdu012","volume":"25","author":"D Schmid","year":"2014","unstructured":"Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293\u2013311.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13102-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T20:02:01Z","timestamp":1731355321000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13102-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13102"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13102-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the Hamburg Medical Association (2023-101090-BO-ff). All participants gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1379"}}